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Abstract
Background: Purpose of this study was to examine pupil size changes and mobility in
normal subjects and in heart failure (HF) patients.
Methods: Sixteen stable patients with New York Heart Association (NYHA) class II or III
heart failure and sixteen control subjects were studied. Pupillary reaction to light was recorded
and nine parameters from this data were measured, reported and then compared in both
groups of subjects.
Results: Patients with HF had abnormal pupillary function compared with normal subjects.
Pupillary light reflex variables differed significantly between two groups (p < 0.05) except
baseline radius (R1), minimum radius (R2) and time for maximum constriction (T3).
A significant decrease in maximum constriction velocity (VCmax; p < 0.001) and maximum
constriction acceleration (ACmax; p < 0.001) was observed in HF subjects. Furthermore,
significantly higher values in percentage recovery-redilatation (%R; p < 0.001), percentage
R2/R1 (%R2/R1; p < 0.05), latency (T1; p < 0.05) and time for maximum velocity (T2; p < 0.05)
were found in the same group.
Conclusions: Of the parameters studied, R1 and %R are governed mainly by the action of the
sympathetic nervous system, through norepinephrine. The rest are governed mainly by
parasympathetic nervous system, through acetylcholine. The results of our study demonstrate
generalized adrenergic activation and parasympathetic withdrawal, which are present in HF.
(Cardiol J 2010; 17, 1: 65–72)
Key words: pupil mobility, heart failure, adrenergic activation, pupillometry,
prognosis
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Introduction
Heart failure (HF) is a principal complication
of almost all forms of heart disease [1]. HF is de-
fined as a complex clinical syndrome that can re-
sult from any structural or functional cardiac disor-
der that impairs the ability of the ventricle to fill
with, or eject, blood. The former is the classic form
of systolic HF, while the latter is the diastolic HF
(with preserved ejection fraction). The major symp-
toms of HF are dyspnoea and fatigue (which affect
exercise ability) and fluid retention which may lead
to pulmonary congestion and peripheral oedema.
It is estimated that 4.9 million people in the US
are being treated for HF, with 550,000 new cases
diagnosed each year. The prevalence of HF has
dramatically increased over the past few decades
as the population ages, with a mean age of the HF
population being 74 years old [2]. The prognosis for
HF is poor if the underlying condition cannot be
rectified. HF has an enormous economic impact on
health care systems and, despite the progress in
medical treatment with beta-adrenergic blockers
and angiotensin-converting enzyme inhibitors,
mortality remains high [3–6].
The accuracy of diagnosis by clinical means
alone is often inadequate, especially in women, eld-
erly and obese. To access properly the prognosis and
to optimize the treatment of HF, diagnostic dilem-
mas must be minimized. So, the introduction of ad-
ditional markers that could evaluate disease progress
in patients with HF and contribute to risk stratifica-
tion is therefore of great significance [7, 8].
HF is characterized by generalized adrenergic
activation and parasympathetic withdrawal [9, 10].
Under normal conditions, the inhibitory inputs from
arterial and cardiopulmonary baroreceptor afferent
nerves are the principal influence on sympathetic
outflow. Parasympathetic control of heart rate is
also under potent arterial baroreflex control. Effer-
ent sympathetic traffic and arterial catecholamines
are low, and heart rate variability is high. As HF
progresses, the inhibitory input from arterial and
cardiopulmonary receptors decreases and excitato-
ry input increases. The net response to this altered
balance includes a generalized increase in sympa-
thetic nerve traffic, blunted parasympathetic and
sympathetic control of heart rate and impairment
of the reflex sympathetic regulation of vascular re-
sistance [9]. Although there are no doubts about the
importance of neuroendocrine mechanisms in the
pathogenesis of HF, the role of neuroendocrine fac-
tors in diagnosis and prognosis is less clear. Plas-
ma noradrenaline increases with age and healthy
subjects over the age of 75 may have plasma con-
centrations of noradrenaline in the HF range [11].
Pupillometry is a simple, non-invasive tech-
nique that provides valuable data concerning the
balance of both branches of autonomous nervous
system [12–15]. Assessment of pupil reflex has
previously been used in alcoholism [16], Down’s
syndrome [17], depression [18, 19], generalized
anxiety disorder [20], drug abuse [21, 22], mental
retardation [23], Alzheimer’s disease [15, 24–30],
and Parkinson’s disease [31, 32].
Our aim in this study was to examine pupil size
changes and mobility optically in HF patients and
to identify simple markers that could be used in the
diagnosis of HF and could accurately predict ad-
verse events, especially death and hospitalization.
Methods
Study population
Heart failure patients. Sixteen patients were
recruited from the cardiology ward of the 1st Depart-
ment of Cardiology, AHEPA Hospital, Aristotle
University of Thessaloniki, Greece. All were pa-
tients with symptomatic HF, New York Heart As-
sociation (NYHA) class II or III at optimal medical
treatment, matching the Framingham criteria for
the diagnosis of HF. The aetiology of HF was coro-
nary artery disease in 12 cases and idiopathic dilat-
ed myocardiopathy in the other four. The diagno-
sis of HF was established by clinical evaluation and
laboratory testing, using invasive and noninvasive
tests including electrocardiography (ECG), chest
roentgenogram, echocardiogram and coronary
angiography as clinically indicated [7, 8, 33]. The
mean age was 67.5 ± 11.2 and the mean left
ventricular ejection fraction was 32 ± 0.06%.
Patients had visual acuity of 10/10 or corrected,
and no history of ocular abnormalities or ocular trau-
ma. Exclusion criteria were systemic conditions with
known ocular involvement, systemic medication with
known central nervous system effect, use of topical
eye treatment and neurological or psychiatric illness.
Control subjects. Sixteen normal sedentary
controls were selected on the basis that they were
both age- and sex-matched with respect to the pa-
tients. They were all randomly selected among hos-
pital staff, patients, relatives and visitors, and had
no past medical history.
The whole study was conducted in the Labo-
ratory of Clinical Neurophysiology in the Aristotle
University of Thessaloniki, AHEPA Hospital, Thes-
saloniki, Greece. All subjects provided written in-
formed consent and all experiments were approved
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by the Ethical Committee of the AHEPA Universi-
ty Hospital based on the Helsinki Declaration. All
subjects underwent standard blood and biochemi-
cal laboratory tests, and went through a full oph-
thalmological evaluation. All subjects were tested
between 09:00 and 15:00.
Infrared pupillometry
Pupillary measurements were taken with a ful-
ly automated system which includes:
1. A CCD high speed digital camera: up to
262 frames per second with maximum sensitivity
in the red and infra-red region of the spectrum.
2. A computer and the associated sampling cards.
3. A light source: two independent light sour-
ces are used in the system: a) an infra-red
light source which illuminates the face of the
person, consists of an array of 32 LEDs with
820 nm wavelength and is switched on perma-
nently throughout the measurement and
b) a clinical photic stimulator (SLE), made by
Bio-logic Systems Corporation UK. A light
flash is produced by a light bulb, through the
discharge of a capacitor, with 20 ms duration.
4. A traversing mechanism: the whole instrument
is based on an optical examination table with
a head rest fixing the position of the head on one
side. On the top of the table, the camera is fixed
on a mechanism which can move in the three,
x-y-z, directions. There is also a capability to ro-
tate the camera on both the x-y and the x-z planes.
5. Image processing analysis which executes
the calculations of the pupil reflex in real-time.
The camera is capable of taking a maximum of
262 frames per second. The actual speed of the
camera is controlled by the software develo-
ped for this purpose.
Because of the corneal curvature and, in order
to avoid errors due to optical distortion, the cam-
era was set normal to the axis of the eye and at
a distance of 30 cm, so that the image of the pupil
was symmetrical.
Experimental conditions
Subjects were asked to spend two minutes in the
examination room to allow their pupils to adjust to the
low lighting conditions. Each subject sat upright on
a chair and rested their chin and forehead against the
construction’s special positions and fixated an infra-
red light in the same axis with the camera, at a dis-
tance of 1.5 m. Then five rectangular light flashes, with
a 30 s interval, were administered.
The test was applied five times on each eye of
each subject to test the repeatability and accuracy of
the system. The duration of the stimulus was 20 ms
and the luminance 24.6 candelas/m2. In the interval of
30 s a full record is completed and in the same period
we had to decide whether this record should be re-
jected or be saved if it was free of any artefacts. At
the end of each measurement trial, a full record of the
pupil’s reaction radius and centre, as a function of time,
was recorded and then analyzed online. From this data
latency, velocity and acceleration were calculated, as
well as other relevant parameters.
Parameters measured
Five artefact-free pupil response curves were
easily obtained for each person. No one complained
of discomfort and everyone was able to finish the test.
Blinking necessitated repeating the test. Parameters
measured were (Fig. 1): baseline pupil radius after
Figure 1. Pupil size after two minutes’ dark adaptation
before pupils’ reaction to light, maximum constriction
and redilation as response to light stimulus. Parameters
measured: latency (T1), time for maximum velocity (T2),
time for maximum constriction (T3), amplitude (AMP),
baseline radius (R1), minimum radius (R2), maximum
constriction velocity (VCmax), and maximum constric-
tion acceleration (ACmax).
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two-minutes dark adaptation (R1); latency for the
onset of constriction (T1); minimum pupil radius af-
ter pupil’s reaction to light (R2); maximum constric-
tion velocity (VCmax); maximum constriction accel-
eration (ACmax); time for maximum velocity (T2);
time for maximum constriction [this is defined as the
time when the constriction velocity is zero  (T3)];
3.5 s percentage recovery-redilatation (this is defined
as the ratio of final pupil radius/baseline pupil radius
at the end of the measurement which lasts 3.5 s —
R%);  R2/R1 ratio (R2/R1%).
The measurement and recording necessary to
obtain the above parameters covered the changes
to the size of the pupil for a period of 3.5 s from the
application of the light flash.
Each measurement of total duration of 3.5 s corre-
sponds to a full record of the reaction of the pupil, start-
ing from the reduction of the diameter, the attainment
of maximum miosis and the return to normal.
Radius measurement. The use of the radius
instead of the diameter seems more reliable and
appropriate. It can be used even when the upper lid
covers part of the pupil and thus reduces the
number of trials the researcher is obliged to drop.
On the other hand, it is very easy to translate all
data using radius to diameter: values are multiplied
with the factor ‘two’.
Statistical analysis
All statistical analyses were calculated accord-
ing to the averaged measurements of five artefact-
free pupillary light reflex (PLR) curves, of the right
eye as no statistical difference was found between the
two eyes (p > 0.89; Fig. 2) [37, 38]. PLR variables
Figure 2. Typical pupil light reflex curve of a normal (A) and a heart failure patient (B) of matching age and gender.
The difference in amplitude (AMP), maximum constriction velocity (VCmax), and maximum constriction acceleration
(ACmax) is obvious between the two subjects.
Radius
Velocity
Acceleration
A. Normal B. Heart failure
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were normally distributed and were summarized
with means and standard deviations for both the nor-
mal and the HF group. The Pearson product moment
correlation coefficient (r) was employed to calculate
the relationships among all depended variables for
the 32 subjects and for the normal and heart failure
groups separately. The differences between the
mean scores of the two groups for all the dependent
variables were assessed with the t-test. In order
to illustrate the classification and discrimination
accuracy of the pupillary light reflexes, we also per-
formed receiver operating characteristic (ROC)
curve analyses. The area under the curve (AUC) of
the ROC curves was estimated and used as the in-
dex of classification accuracy, where a variable with
an AUC = 1 indicates perfect discrimination ability
into HF or normal group, while a variable with an
AUC near 0.5 indicates poor discrimination ability
into the two groups. Analyses were conducted in
SPSS 14 (SPSS Inc., Chicago, IL, USA).
Results
Correlations among all the PLR variables for
the 32 subjects, and for the normal and HF patient
groups separately, are listed in Table 1. Paired
t-test analysis was then employed to examine the
differences between the mean scores of the two
matched groups for all PLR variables. This revealed
significant differences between them for six out of
nine PLR variables (Table 2). Specifically, the mean
values of VCmax (p < 0.001) and ACmax (p < 0.001)
were significantly lower in HF subjects compared
to control subjects. Conversely, the mean scores of
T1 (p < 0.05), T2 (p < 0.05), %R (p < 0.001) and
%R2/R1 (p < 0.05) were significantly higher in the
HF group compared to the control group. There was
no significant difference between the two groups for
R1, R2 and T3. Table 3 provides evidence of the clas-
sification power of the best PLR variable in discrim-
inating the subjects of the two groups. ACmax was
Table 1. Pearson correlation of pupillary light reflex variables, overall and within normal and heart failure
(HF) group.
R2 %R T1 T2 T3 VCmax ACmax %R2/R1
R1
Normal 0.927** 0.444 0.178 0.512** 0.341 0.459 0.122 0.247
HF 0.971** 0.478 –0.296 –0.437 –0.602* 0.395 –0.505* 0.081
R2
Normal 0.744** 0.010 0.331 0.497 0.225 0.192 0.517*
HF 0.671** –0.245 –0.501* –0.536* 0.407 –0.358 0.257
%R
Normal –0.321 –0.130 0.653** –0.314 0.295 0.798**
HF 0.060 –0.449 –0.100 0.297 0.264 0.703**
T1
Normal 0.111 –0.171 0.728** 0.236 –0.088
HF 0.207 0.021 0.182 0.172 0.123
T2
Normal –0.365 0.542* –0.480 –0.417
HF 0.267 0.119 0.338 –0.410
T3
Normal –0.410 0.599* 0.499*
HF –0.189 0.429 –0.022
VCmax
Normal –0.025 –0.191
HF –0.019 –0.183
ACmax
Normal 0.336
HF 0.439
*Correlation is significant at p < 0.05 level; **correlation is significant at p < 0.01 level; R1 — baseline pupil radius; R2 — minimum pupil radius;
%R — 3.5 s percentage recovery-redilatation; T1 — latency; T2 — time for maximum velocity; T3 — time for maximum constriction; VCmax —
maximum constriction velocity; ACmax — maximum constriction acceleration; %R2/R1 — R2/R1 ratio
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the best predictor in determining a subject to be
a HF patient (AUC = 1) leaving VCmax in second
place, with almost perfect classification ability (AUC
= 0.998), and %R and %R2/R1 in third and fourth
places, also with high classification ability (AUC =
= 0.908 and AUC = 0.848, respectively). R1 and
R2 were ranked last with a lower AUC, indicating
poor classification power in discriminating between
the two groups (p = 0.05 and p = 0.821, respective-
ly). Figure 2 shows the average curves of VCmax,
ACmax and R1 of the right eye in normal subjects
and HF patients after two minutes’ adaptation,
before and after the pupils’ reaction to light.
Discussion
To the best of our knowledge, this is the first
study that has evaluated pupil size and mobility for
the assessment of the autonomic nervous system
in patients with HF. In this study, pupillometric
measurements were taken by a standardized, fully
automated, unique pupillometry system. The accu-
racy of this pupillometry system has successfully
been proved in previous studies [37, 38]. The se-
lection of  patients who entered the study was strict-
ly according to the inclusion and exclusion criteria;
the control group was perfectly age- and sex-
-matched to the patient group. The examination con-
ditions were identical for all subjects, adding to the
reliability of the results of the present investigation.
Pupillometry is widely used to assess the bal-
ance of both branches of the autonomic nervous
system (ANS), based on the fact that the size and
reaction of the human pupil are under the antago-
nistic action of the parasympathetic nervous sys-
tem (ParN) and the sympathetic nervous system
(SNS) [24]. Furthermore, in the absence of a docu-
mented peripheral disorder of the ANS, pupil size
reflects the integrated output of the sympathetic
and parasympathetic pathways. The cardiac sympa-
thetic nerves are preferentially stimulated in severe
HF, with Nor release from the failing heart at rest
in untreated patients increased up to 50-fold, which
is similar to the levels of release in healthy hearts
during near-maximal exercise [34].
The precision of results is significantly higher
for latency, velocity and acceleration when a sam-
Table 2. Descriptive statistics for pupillary light reflex variables for normal and heart failure groups.
  Normal (n = 16) Heart failure (n = 16) p*
Min Max Mean SD Min Max Mean SD
R1 1.355 3.740 2.770 0.659 1.950 2.827 2.434 0.275 0.074
R2 0.931 2.881 2.020 0.559 1.460 2.415 1.981 0.295 0.808
%R 58.651 79.486 72.390 5.073 72.183 89.190 81.046 4.849 < 0.001
T1  0.200 0.265 0.233 0.018 0.208 0.272 0.249 0.021 0.030
T2 0.273 0.354 0.323 0.022 0.284 0.384 0.344 0.027 0.021
T3 0.712 0.773 0.740 0.023 0.740 0.860 0.740 0.078 0.990
VCmax 2.904 –2.032 –2.402 0.241 –2.095 –1.557 –1.825 0.175 < 0.001
ACmax –32.087 –19.229 –24.601 3.356 –15.329 –12.480 –14.196 0.274 < 0.001
%R2/R1 81.164 97.443 93.960 4.107 95.470 99.850 97.486 1.292 0.004
*Paired t-test and p < 0.05 considered significant; R1 — baseline pupil radius; R2 — minimum pupil radius; %R — 3.5 s percentage recovery-
-redilation; T1 — latency; T2 — time for maximum velocity; T3 — time for maximum constriction;  VCmax — maximum constriction velocity;
ACmax — maximum constriction acceleration; %R2/R1 — R2/R1 ratio; SD — standard deviation
Table 3. Classification accuracy of pupillary light
reflexes.
PLR AUC 95% CI p*
ACmax 1.000 1.000–1.000 < 0.001
VCmax 0.988 0.963–1.000 < 0.001
%R 0.906 0.807–1.000 < 0.001
%R2/R1 0.848 0.715–0.980 < 0.001
T2 0.768 0.594–0.941 0.010
T1 0.766 0.592–0.939 0.010
T3 0.553 0.326–0.780 0.611
R2 0.477 0.265–0.689 0.821
R1 0.297 0.107–0.487 0.005
*p < 0.05 considered significant; CI — confidence interval;
PLR — pupillary light reflex; R1 — baseline pupil radius; R2 —
minimum pupil radius; %R — 3.5 s percentage recovery-redilation;
T1 — latency; T2 — time for maximum velocity; T3 — time for
maximum constriction; VCmax — maximum constriction velocity;
ACmax — maximum constriction acceleration; %R2/R1 —
R2/R1 ratio; AUC — area under the curve
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pling rate of 300 frames/s is used, when the exper-
imental procedure is repeated at least four times,
and when the results are averaged [39]. This high
sampling rate was also used in our study (263 fra-
mes/s), and the average of five flash measure-
ments was calculated. In view of the strict selec-
tion of subjects (normal and HF patients), as well
as the method used, our results may be considered
reliable.
In accordance with the central nervous system
integratory mechanisms that govern the PLR, the
characteristic V-shaped response is divided into
three segments: a primary that is due exclusively
to ParNS excitation; a middle that is attributed both
to the SNS and the ParNS; and a latter that reflects
only SNS activity [35]. Thus it is evident that the
parameters involved in the first segment, especial-
ly ACmax and VCmax, are extremely sensitive in-
dicators of cholinergic activity. On the other hand,
the resting pupil diameter is mainly under sympa-
thetic control and the diameter reduction is a sign
of diminished sympathetic outflow to the iris mus-
cles [36]. Additionally, the most sensitive indica-
tor of SNS activity resides in the third segment of
the V-shaped response. Thus %R can be used as
an indicator of SNS activity [35].
In our study, HF patients had significantly low-
er levels of VCmax and ACmax compared with nor-
mal subjects. Conversely, HF patients had signifi-
cantly higher levels of %R, T1, T2, %R2/R1 com-
pared with normal subjects. There was no signifi-
cant difference between the two groups for R1, R2
and T3. The low levels of ACmax and VCmax indi-
cate a cholinergic deficit in HF derived from a blunt-
ed parasympathetic system. The high levels of
%R2/R1, and especially %R, are indicative of an
increased adrenergic activity with increased levels
of circulating norepinephrine. Another very impor-
tant observation is that ACmax was the best pre-
dictor in classifying a subject as HF or normal.
Limitation of the study
Pupillometry cannot be used in patients suffer-
ing from retinopathy or other ophthalmological,
psychiatric or neurological diseases, because pupil
mobility may be affected and lead to false conclu-
sions.
A low percentage of our patients were under
treatment with beta-blockers that could possibly
interfere with pupil size and mobility. However, we
know of no reference currently available concern-
ing the possible effect of the systematic use of such
medication on pupil size and mobility.
The size of our sample is small but the statis-
tically significant difference allows us to draw ear-
ly conclusions. This is the first study ever that has
used pupil size changes and mobility to evaluate
autonomic imbalance in patients with HF. Howev-
er, this is only a preliminary report and further stud-
ies are encouraged to replicate the above findings.
Conclusions
All parameters analyzed here, except baseline
pupil radius (R1), minimum pupil radius (R2) and
time for maximum constriction (T3) revealed sta-
tistically significant differences between HF pa-
tients and normal subjects. This is an indication of
abnormal pupillary function in HF patients com-
pared with healthy subjects. However, the most
important finding is that ACmax is the best predic-
tor of subject classification as normal or HF.
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